David T. Miller
Boston Children's Hospital · 124 works · 14,322 citations · h-index 52
Top works
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies
- Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
- Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration
- Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders
- Exploring concordance and discordance for return of incidental findings from clinical sequencing
- Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders
- ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
- Clinical Genetic Testing for Patients With Autism Spectrum Disorders
- Blastic Natural Killer Cell Leukemia/Lymphoma: A Clinicopathologic Study
- Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region
- Association of Common CRP Gene Variants with CRP Levels and Cardiovascular Events
- ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
- Microarray‐based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics
- Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–Gilford progeria syndrome
- Deletions of NRXN1 (neurexin‐1) predispose to a wide spectrum of developmental disorders
- Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes
- Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
- ZLocal induction of patterning and programmed cell death in the developing Drosophila retina
- ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
- Health Supervision for Children With Neurofibromatosis Type 1